Professor Shahina Pardhan to lead new vision research unit

Article

Professor Shahina Pardhan has been appointed director of Anglia Ruskin University's new Vision and Eye Research Unit (VERU).

Professor Shahina Pardhan has been appointed director of Anglia Ruskin University’s new Vision and Eye Research Unit (VERU).

Professor Pardhan has an extensive background in optometry and research based on the clinical assessment of visual functions in range of normal and abnormal ocular conditions including myopia, low vision and normal vision. She was the first woman to become Professor of Optometry at Anglia Ruskin University and has been awarded the Asian Jewel Award (Health care and education category) and the Asian Women of Achievement award.

Talking to the Cambridge Network she said: "I am really looking forward to this exciting new venture and working with vision and eye researchers both within Anglia Ruskin and externally. We have an outstanding team here, offering world-leading expertise which is already proving attractive to organisations seeking to fulfil their research and development needs."

VERU will build on existing collaborations and build new research partnerships both in- and outside the university, including the NHS and partners in the optical and pharmaceutical industries. Other experts involved with the unit include Professor Rupert Bourne, Professor of Ophthalmology at Anglia Ruskin, Professor Roger Buckley, Professor of Ocular Medicine at Anglia Ruskin and Dr Sarah Waugh, Reader in the Department of Optometry and Ophthalmic dispensing at Anglia Ruskin.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.